These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33602652)

  • 1. Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancer.
    Nugteren S; Samsom JN
    Cytokine Growth Factor Rev; 2021 Jun; 59():22-35. PubMed ID: 33602652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory leukocyte protease inhibitor inhibits expression of polymeric immunoglobulin receptor via the NF-κB signaling pathway.
    Mikami Y; Iwase T; Komiyama Y; Matsumoto N; Oki H; Komiyama K
    Mol Immunol; 2015 Oct; 67(2 Pt B):568-74. PubMed ID: 26239418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous secretory leukocyte protease inhibitor inhibits microbial-induced monocyte activation.
    Nugteren S; Simons-Oosterhuis Y; Menckeberg CL; Hulleman-van Haaften DH; Lindenbergh-Kortleve DJ; Samsom JN
    Eur J Immunol; 2023 Feb; 53(2):e2249964. PubMed ID: 36480463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism.
    Fakioglu E; Wilson SS; Mesquita PM; Hazrati E; Cheshenko N; Blaho JA; Herold BC
    J Virol; 2008 Oct; 82(19):9337-44. PubMed ID: 18667508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.
    Schmid M; Fellermann K; Fritz P; Wiedow O; Stange EF; Wehkamp J
    J Leukoc Biol; 2007 Apr; 81(4):907-15. PubMed ID: 17200145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
    Påhlman LI; Jögi A; Gram M; Mori M; Egesten A
    BMC Pulm Med; 2015 Mar; 15():19. PubMed ID: 25851169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis.
    Nugteren S; Goos JACM; Delis-van Diemen PM; Simons-Oosterhuis Y; Lindenbergh-Kortleve DJ; van Haaften DH; Sanders J; Meijer GA; Fijneman RJA; Samsom JN
    Oncoimmunology; 2020 Oct; 9(1):1832761. PubMed ID: 33101778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure.
    Antoniades CG; Khamri W; Abeles RD; Taams LS; Triantafyllou E; Possamai LA; Bernsmeier C; Mitry RR; O'Brien A; Gilroy D; Goldin R; Heneghan M; Heaton N; Jassem W; Bernal W; Vergani D; Ma Y; Quaglia A; Wendon J; Thursz M
    Hepatology; 2014 Apr; 59(4):1564-76. PubMed ID: 24282114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory leukocyte protease inhibitor (SLPI) in cancer pathophysiology: Mechanisms of action and clinical implications.
    Zhang X; Liu SS; Ma J; Qu W
    Pathol Res Pract; 2023 Aug; 248():154633. PubMed ID: 37356220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation.
    Lentsch AB; Jordan JA; Czermak BJ; Diehl KM; Younkin EM; Sarma V; Ward PA
    Am J Pathol; 1999 Jan; 154(1):239-47. PubMed ID: 9916938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.
    Jana NK; Gray LR; Shugars DC
    J Virol; 2005 May; 79(10):6432-40. PubMed ID: 15858026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretory leukocyte protease inhibitor modulates urethane-induced lung carcinogenesis.
    Jan Treda C; Fukuhara T; Suzuki T; Nakamura A; Zaini J; Kikuchi T; Ebina M; Nukiwa T
    Carcinogenesis; 2014 Apr; 35(4):896-904. PubMed ID: 24282288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease inhibitory activity of secretory leukocyte protease inhibitor ameliorates murine experimental colitis by protecting the intestinal epithelial barrier.
    Ozaka S; Sonoda A; Ariki S; Kamiyama N; Hidano S; Sachi N; Ito K; Kudo Y; Minata M; Saechue B; Dewayani A; Chalalai T; Soga Y; Takahashi Y; Fukuda C; Mizukami K; Okumura R; Kayama H; Murakami K; Takeda K; Kobayashi T
    Genes Cells; 2021 Oct; 26(10):807-822. PubMed ID: 34379860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of secretory leukocyte protease inhibitor in middle ear cholesteatoma.
    Lee JK; Chae SW; Cho JG; Lee HM; Hwang SJ; Jung HH
    Eur Arch Otorhinolaryngol; 2006 Dec; 263(12):1077-81. PubMed ID: 16868773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory leukoprotease inhibitor in mucosal lymph node dendritic cells regulates the threshold for mucosal tolerance.
    Samsom JN; van der Marel AP; van Berkel LA; van Helvoort JM; Simons-Oosterhuis Y; Jansen W; Greuter M; Nelissen RL; Meeuwisse CM; Nieuwenhuis EE; Mebius RE; Kraal G
    J Immunol; 2007 Nov; 179(10):6588-95. PubMed ID: 17982048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines.
    Svensson D; Aidoukovitch A; Anders E; Jönsson D; Nebel D; Nilsson BO
    Inflamm Res; 2017 Sep; 66(9):823-831. PubMed ID: 28597116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory leukocyte peptidase inhibitor and lung cancer.
    Nukiwa T; Suzuki T; Fukuhara T; Kikuchi T
    Cancer Sci; 2008 May; 99(5):849-55. PubMed ID: 18380788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory leukocyte protease inhibitor promising protective roles in obesity-associated atherosclerosis.
    Zhong QQ; Wang X; Li YF; Peng LJ; Jiang ZS
    Exp Biol Med (Maywood); 2017 Feb; 242(3):250-257. PubMed ID: 27698252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor.
    Mulligan MS; Lentsch AB; Huber-Lang M; Guo RF; Sarma V; Wright CD; Ulich TR; Ward PA
    Am J Pathol; 2000 Mar; 156(3):1033-9. PubMed ID: 10702419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice.
    Nakamura A; Mori Y; Hagiwara K; Suzuki T; Sakakibara T; Kikuchi T; Igarashi T; Ebina M; Abe T; Miyazaki J; Takai T; Nukiwa T
    J Exp Med; 2003 Mar; 197(5):669-74. PubMed ID: 12615907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.